SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Cleveland-Cliffs, Inc. is a flat-rolled steel company, which engages in provision of iron ore pellets to the North American steel industry. It focuses on the production of metallic and coke, iron making, steelmaking, rolling and finishing, and downstream tubular components, stamping, and tooling. The company was founded in 1847 and is headquartered in Cleveland, OH.

Cleveland-Cliffs Inc

Cleveland-Cliffs is trending after a sharp post-earnings decline, exacerbated by the CEO's recent significant share sale, fueling community debate over management's performance and the ongoing POSCO strategic partnership talks. Despite widespread criticism and skepticism regarding the company's debt and profitability, a segment of the community is buying the dip, banking on an anticipated 2026 turnaround from cost reductions and increased steel shipment volumes.

The Compound Governance Token is a governance token on the Compound Finance lending protocol, COMP allows the owner to delegate voting rights to the address of their choice; the owner’s wallet, another user, an application, or a DeFi expert. Anybody can participate in Compound governance by receiving delegation, without needing to own COMP.  Anybody with 1% of COMP delegated to their address can propose a governance action; these are simple or complex sets of actions, such as adding support for a new asset, changing an asset’s collateral factor, changing a market’s interest rate model, or changing any other parameter or variable of the protocol that the current administrator can modify.

Compound

Compound (COMP) is a trending crypto, with community discussion polarized between optimism for its nearing max token supply, potential V4 updates, and new partnerships, versus significant concerns regarding its Foundation's performance, declining Total Value Locked, and intense competition from rivals like AAVE.

Transocean Ltd. engages in the provision of offshore contract drilling services for oil and gas wells. It also owns and operates offshore drilling fleets such as ultra-deepwater, harsh environment, deepwater, and midwater rigs. The company was founded in 1953 and is headquartered in Steinhausen, Switzerland.

Transocean Ltd

Transocean (RIG) is trending strongly following its all-stock acquisition of Valaris (VAL), a transformative deal seen by the community as creating a dominant offshore drilling leader with significant backlog and pricing power. This major sector consolidation is fueling optimism for a sustained turnaround, boosted by anticipated strong financial performance from upcoming earnings and potential for a short squeeze.

Disc Medicine, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of treatments for hematologic diseases. It assembles a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, specifically heme biosynthesis and iron homeostasis. The company was founded in October 2017 and is headquartered in Watertown, MA.

Disc Medicine Inc

Disc Medicine is a major topic as the FDA declined accelerated approval for its rare disease drug bitopertin, causing a sharp decline in shares. The community is debating whether this is an overreaction, with many highlighting the potential for traditional approval and the value of other pipeline assets like DISC-0974.

Medtronic Plc is a medical technology company, which engages in the development, manufacture, distribution, and sale of device-based medical therapies and services. It operates through the following segments: Cardiovascular Porrtfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment includes products for the diagnosis, treatment, and management of cardiac rhythm disorders and cardiovascular disease. The Neuroscience Portfolio is made up of cranial and spinal technologies, specialty therapies, and neuromodulation divisions. The Medical Surgical Portfolio is comprised of surgical innovations and respiratory, gastrointestinal, and renal divisions. The Diabetes Group segment offers insulin pumps, continuous glucose monitoring systems, and insulin pump consumables. The company was founded in 1949 and is headquartered in Dublin, Ireland.

Medtronic Plc

Medtronic is trending as it strategizes to spin off its Diabetes business, a move seen by the community as a way to unlock value and boost focus on high-growth segments like surgical robotics and cardiovascular, further supported by a series of recent FDA approvals.

Celsius Holdings, Inc. engages in the development, marketing, sale, and distribution of functional drinks and liquid supplements. It also offers post-workout functional energy drinks and protein bars. The company was founded in April 2004 and is headquartered in Boca Raton, FL.

Celsius Holdings Inc

Celsius Holdings is actively discussed as PepsiCo's positive commentary on its brand integration and new board member appointments fuel acquisition speculation, while investors anticipate upcoming earnings and a CAGNY conference to confirm its strong growth trajectory. Despite recent price volatility often attributed to market manipulation and short-covering, the community remains bullish on Celsius's underlying product strength and market share gains against competitors in the functional beverage sector.

Genius Sports Ltd. engages in the provision of scalable, technology-led products and services to the sports, sports betting, and sports media industries. It also involves in Sports League, which offers technology infrastructure for the collection, integration, and distribution of live data; Sportsbooks, which includes collection of live sports data, odds making, risk management and player marketing; and Sports Media, which provides a range of online marketing and fan engagement tools. The company was founded by Mark Adrian Locke in 2000 and is headquartered in London, United Kingdom.

Genius Sports Limited

Genius Sports is trending after a controversial $1.2 billion acquisition of Legend, which has triggered a significant sell-off fueled by community concerns over perceived overpayment, increased debt, and dilution, overshadowing the company's strong underlying business performance amid broader sector uncertainty.

Upstream Bio, Inc. is a clinical-stage biotechnology company, which engages in the development of treatments for inflammatory diseases, with an initial focus on severe respiratory disorders. It develops verekitug, the only known antagonist currently in clinical development that targets the receptor for Thymic Stromal Lymphopoietin. The company was founded in April 2021 and is headquartered in Waltham, MA.

Upstream Bio Inc.

Upstream Bio is trending due to a significant stock sell-off following its Phase 2 VALIANT trial results for Verekitug; while efficacy with quarterly dosing was positive, market expectations for a differentiated biannual dosing regimen were not met. The community is divided, with many seeing the sharp decline as an overreaction and a buying opportunity, citing institutional accumulation and the drug's overall potential in the asthma market, while others remain cautious.

Codatta

XNY (Codatta) is attracting significant attention for its remarkable resilience and strong upward momentum, often outperforming Bitcoin during market dips, leading the community to anticipate substantial surges as its AI and decentralized data utility gains broader recognition.

Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.

Capricor Therapeutics Inc

Capricor Therapeutics is trending with community anticipation for its February BLA resubmission, as the FDA's request for the full HOPE-3 clinical study reportwithout needing new trialsreassures many about the regulatory path for its DMD therapy. Further excitement stems from expected updates on its StealthX exosome platform and recent significant institutional investment.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 
